Immunodeficiency Canada is a national registered charity providing patient support, education and research for a cure for Primary Immunodeficiency (PI).
Be part of something big. A new day on the calendar called GivingTuesday! After Black Friday and Cyber Monday, GivingTuesday is the movement that celebrates giving back. Join millions of Canadians and give back to the charities that you care about – donate, on December 1, 2015.
GivingTuesday inspires personal philanthropy and encourages bigger, better and smarter charitable giving during the holiday season, showing that the world truly gives as good as it gets. It proves that the holidays can be about both giving and giving back. It celebrates how Canadians can do more with their wallets then just shop and that we can give as good as we get.
Help Immunodeficiency Canada this GivingTuesday raise $4,500 that will go towards patient support this GivingTuesday. This amount provides 3 grants to 3 families at five different treatment centres which will help them with expenses for 1 month.
100% of your donation will be used for patient support, in thanks to our corporate sponsorship which covers administration costs.
Giving Tuesday starts in ….
Business Analyst-Business Planning-Customer Services,
Bombardier Commercial Aircraft @Bombardier
“Within a week of Bombardier’s Jeans Day Team distributing the 10 Warning Signs of Primary Immunodeficiency (PI), we received a phone call from a patient needing help,” says Richard Thompson, CEO of Immunodeficiency Canada. Read More
Implementation of newborn screening for SCID (Severe Combined Immunodeficiency), a major accomplishment for Immunodeficiency Canada.
“This is a monumental triumph to children born with severe combined immunodeficiency (SCID) and their families. Newborn screening will detect this problem early before complications develop, and allow for prompt life-saving interventions such as bone marrow transplantation. Read More
Learn about Primary Immunodeficiency scientific events.
LymphoSign Journal publishes novel clinical, translational, or basic research articles aimed at clinicians and scientists in the fields of immunology, gastroenterology, neurology, dermatology, infectious diseases, rheumatology, and hematology. The focus is on defining the molecular basis and treatment of various immune disorders like innate or adaptive immunodeficiency, bone marrow failure, autoimmunity and auto inflammatory disorders and lymphoid malignancies. The Journal also publishes papers that can directly and immediately improve diagnosis and management of patients, including practice guidelines and algorithms.